Biomarin Pharmaceutical Stock Math Transform Inverse Tangent Over Price Movement

BMRN Stock  USD 56.68  0.17  0.30%   
Biomarin Pharmaceutical math transform tool provides the execution environment for running the Inverse Tangent Over Price Movement transformation and other technical functions against Biomarin Pharmaceutical. Biomarin Pharmaceutical value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of math transform indicators. As with most other technical indicators, the Inverse Tangent Over Price Movement transformation function is designed to identify and follow existing trends. Analysts that use price transformation techniques rely on the belief that biggest profits from investing in Biomarin Pharmaceutical can be made when Biomarin Pharmaceutical shifts in price trends from positive to negative or vice versa.

Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. Biomarin Pharmaceutical Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe Biomarin Pharmaceutical price patterns.

Biomarin Pharmaceutical Technical Analysis Modules

Most technical analysis of Biomarin Pharmaceutical help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Biomarin from various momentum indicators to cycle indicators. When you analyze Biomarin charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Biomarin Pharmaceutical Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Biomarin Pharmaceutical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Biomarin Pharmaceutical based on widely used predictive technical indicators. In general, we focus on analyzing Biomarin Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Biomarin Pharmaceutical's daily price indicators and compare them against related drivers, such as math transform and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Biomarin Pharmaceutical's intrinsic value. In addition to deriving basic predictive indicators for Biomarin Pharmaceutical, we also check how macroeconomic factors affect Biomarin Pharmaceutical price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2023 2024 2025 2026 (projected)
Days Sales Outstanding95.6184.4897.1599.68
PTB Ratio3.662.211.993.91
Hype
Prediction
LowEstimatedHigh
53.8056.6859.56
Details
Intrinsic
Valuation
LowRealHigh
53.6556.5359.41
Details
Naive
Forecast
LowNextHigh
53.3656.2459.11
Details
29 Analysts
Consensus
LowTargetHigh
82.5790.74100.72
Details

Become your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Did you try this?

Run Money Managers Now

   

Money Managers

Screen money managers from public funds and ETFs managed around the world
All  Next Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Macroaxis Index Idea
Macroaxis Index
Invested over 40 shares
Dividend Beast Idea
Dividend Beast
Invested over 30 shares
Momentum Idea
Momentum
Invested over 30 shares
Investor Favorites Idea
Investor Favorites
Invested over 50 shares
Hedge Favorites Idea
Hedge Favorites
Invested over 200 shares
ESG Investing Idea
ESG Investing
Invested few shares
Climate Change Idea
Climate Change
Invested over 90 shares
Technology Idea
Technology
Invested few shares
Cash Cows Idea
Cash Cows
Invested few shares
Impulse Idea
Impulse
Invested few shares
When determining whether Biomarin Pharmaceutical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biomarin Pharmaceutical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biomarin Pharmaceutical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biomarin Pharmaceutical Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biomarin Pharmaceutical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
To learn how to invest in Biomarin Stock, please use our How to Invest in Biomarin Pharmaceutical guide.
You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Will Biotechnology sector continue expanding? Could Biomarin diversify its offerings? Factors like these will boost the valuation of Biomarin Pharmaceutical. Projected growth potential of Biomarin fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Biomarin Pharmaceutical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
1.243
Earnings Share
2.69
Revenue Per Share
16.165
Quarterly Revenue Growth
0.041
Return On Assets
0.0615
Understanding Biomarin Pharmaceutical requires distinguishing between market price and book value, where the latter reflects Biomarin's accounting equity. The concept of intrinsic value—what Biomarin Pharmaceutical's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Biomarin Pharmaceutical's price substantially above or below its fundamental value.
It's important to distinguish between Biomarin Pharmaceutical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Biomarin Pharmaceutical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Biomarin Pharmaceutical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.